Patient-Directed Record Access: TEFCA, Consent and Provider Responsibilities
Dr. Dereck Mush, MD, MBA
Outcomes4Me
Empowers cancer patients with personalized treatment navigation, symptom tracking, and clinical trials.
What they do
Outcomes4Me develops a patient-facing mobile application that uses artificial intelligence to analyze clinical records. The platform provides cancer patients with personalized, evidence-based treatment options, clinical trial opportunities, and symptom tracking, helping them actively participate in their oncology care decisions.
The record
- Vertical
- Oncology
- Sub-segment
- Patient empowerment platform
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Boston, United States
- Region
- North America
- Founded
- 2017
- Total funding
- $12M raised
Notable investors: JAZZ Venture Partners, Providence Ventures, Asset Management Ventures, Section 32.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
Direct AI Record Access: What TEFCA Changes and What It Does Not
Dr. Dereck Mush, MD, MBA
Hardware Tiering and AI Coaching: How Google's Fitbit Edge Reshapes Continuous Monitoring Economics
Dr. Dereck Mush, MD, MBA
From Remote Telemetry to Active Co-Management: Direct-to-Patient Hemodynamics in Heart Failure
Dr. Dereck Mush, MD, MBA